VIVOLTA Partners with Neurochase to Manufacture Micro-Catheters that Deliver Advanced Therapies to the Brain

Vivolta and Neurochase are working together to create tiny, advanced tools called micro-catheters that can deliver treatments directly to specific parts of the brain. This innovative approach could improve care for people with Parkinson’s disease and other neurological conditions by helping medications reach areas of the brain that are hard to target due to the blood-brain barrier. The partnership uses Vivolta’s MediSpin technology, which makes super-small fibers that mimic natural tissue, enhancing Neurochase’s drug delivery system. This system allows for precise, safe treatment delivery with minimal surgery, even while patients are awake. With clinical trials planned for 2025, this breakthrough could lead to more effective therapies for Parkinson’s and other brain disorders, offering hope for better outcomes.